Stocktoria

ImageneBio, Inc. IMA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-03-26

ImageneBio, Inc. statistics & valuation

Market cap$71.1M
P / S88.9×
P / B0.5×
Net margin-5668.6%
Return on equity-34.1%
Return on capital-34.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-481.40% -110.10% -440.30% -744.20% -1044.80% -5668.60% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-484.20% -110.20% -454.00% -823.30% -1057.10% -6056.40% 202020212022202320242025
Return on equity (%)
-16.40% -46.80% -34.10% 202020212022202320242025
Shares outstanding
3.1M 36.0M 36.3M 48.3M 48.3M 4.9M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-26.30% -13.80% -39.90% -35.50% -229.70% -29.60% 202020212022202320242025
Free cash flow margin (%)
-419.80% -200.10% -483.70% -875.10% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$1.22 -$1.90 -$1.63 -$22.10 -$9.64 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-6056.4%-1057.1%-823.3%-454.0%-110.2%-484.2%
Net margin-5668.6%-1044.8%-744.2%-440.3%-110.1%-481.4%
FCF margin——-875.1%-483.7%-200.1%-419.8%
Return on assets-29.6%-229.7%-35.5%-39.9%-13.8%-26.3%
Return on equity-34.1%22.8%54.1%-46.8%-16.4%43.8%
Current ratio12.490.7212.587.448.705.86

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.